Search results
Merck Gambled With Keytruda In 2011 — How That Jump Is Still Paying Off Today
Investor's Business Daily· 2 years agoA gamble Merck made more than 10 years ago could pay off again for the pharmaceutical giant's stock...
Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
Reuters via Yahoo News· 2 years agoU.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy...
Merck scraps Keytruda trial for prostate cancer after dismal interim data
Reuters via Yahoo News· 1 year agoThe interim analysis showed the therapy did not extend survival or help extend the time a patient...
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
Merck's (MRK) Keytruda Receives EU Nod in Gastric Cancer
Zacks via Yahoo Finance· 10 months agoFollowing the approval, Merck's (MRK) Keytruda is the first immunotherapy approved in the EU for...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 3 weeks agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Merck scraps third prostate cancer study as Keytruda therapy disappoints
Reuters via Yahoo News· 1 year agoMerck & Co on Tuesday scrapped a late-stage trial of a combination therapy with its cancer drug...
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma...
Benzinga via Yahoo Finance· 1 month agoMonday, Merck & Co Inc (NYSE:MRK) announced the discontinuation of the vibostolimab and...
Immunotherapy drugs helps in fight against cancer, explains Savannah doctor
Savannah Morning News via Yahoo News· 8 months agoImmunotherapy is a recent addition to the arsenal of weapons used against cancer. A Savannah area...
Merck (MRK) Keytruda Advanced Gastric Cancer Study Meets Goal
Zacks via Yahoo Finance· 2 years agoTop-line data from a late-stage study shows that Merck's (MRK) Keytruda combined with chemotherapy...